Krebs Biochemicals & Industries Limited (NSE:KREBSBIO)
India flag India · Delayed Price · Currency is INR
59.80
+0.31 (0.52%)
Feb 19, 2026, 3:29 PM IST

Krebs Biochemicals & Industries Company Description

Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India.

The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications.

The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications.

In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies.

Krebs Biochemicals & Industries Limited was incorporated in 1991 and is based in Visakhapatnam, India.

Krebs Biochemicals & Industries Limited
CountryIndia
Founded1991
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees202
CEOManish Jain

Contact Details

Address:
Kothapalli Village
Visakhapatnam, 531031
India
Phone91 91 2114 4984
Websitekrebsbiochem.com

Stock Details

Ticker SymbolKREBSBIO
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE268B01013
SIC Code2833

Key Executives

NamePosition
Manish Kumar JainMD, Chief Executive Officer and Director
Rakesh R. KalbateCompany Secretary and Compliance Officer
Ritesh JainChief Financial Officer